INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 172 filers reported holding INTERSECT ENT INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,255,000 | +53.9% | 57,380 | +26.9% | 1.09% | +29.3% |
| Q4 2017 | $1,465,000 | +160.7% | 45,210 | +150.5% | 0.84% | +139.2% |
| Q3 2017 | $562,000 | -18.9% | 18,045 | -27.3% | 0.35% | -23.6% |
| Q2 2017 | $693,000 | -31.2% | 24,810 | -42.4% | 0.46% | -49.2% |
| Q3 2015 | $1,007,000 | -9.4% | 43,054 | +11.0% | 0.91% | +13.2% |
| Q2 2015 | $1,111,000 | – | 38,795 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |